FDA seeks 'complementary approach' to regulating LDTs

In a discussion paper addressing regulation of laboratory-developed tests, FDA said it is continuing to evaluate comments and proposals from stakeholders to determine an appropriate way to regulate

Read the full 281 word article

User Sign In